the only thing that is important is PNV continue its sales growth not how many academic journal articles are published. It is no doubt pleasing that some many academic are choosing to publish on BTM, but at the end of the day, we need to make increasing sales and turn a profit. The more the merrier for everybody from shareholders to doctors to patients.
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-587
-
- There are more pages in this discussion • 464 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.54 |
Change
0.120(4.96%) |
Mkt cap ! $1.754B |
Open | High | Low | Value | Volume |
$2.50 | $2.54 | $2.43 | $4.835M | 1.931M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 81780 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.54 | 5610 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 81780 | 2.520 |
3 | 10984 | 2.510 |
2 | 14823 | 2.500 |
2 | 14823 | 2.490 |
2 | 28063 | 2.480 |
Price($) | Vol. | No. |
---|---|---|
2.540 | 5610 | 4 |
2.550 | 32017 | 8 |
2.560 | 29288 | 5 |
2.570 | 19781 | 3 |
2.580 | 11846 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |